Founder and CEO Julian Andriesz, along with COO James Grant Wetherill, spoke to Chloe Kent on all things Verita for the January Edition of Verdict’s Medical Technology Magazine.

They touched on the company’s latest acquisitions and technologies and their focus on prevention and proactive wellness over kneejerk cures.

They also previewed what the rest of 2020 has in store for the firm.  

You can read the article in full here:

https://medical-technology.nridigital.com/medical_technology_jan20/q_a_how_tech_can_unleash_preventative_personalised_medicine_with_verita

Dr Alexander G. Haslberger, Professor from the University of Vienna and Verita board member, was featured in Monday’s (16 December) edition of The Times, discussing whether we should redefine ageing and treat it like a disease. The supplement, put together by publisher Raconteur, saw Professor Alexander comment on how best to define ageing and the results of the recent TAME (Targeted Ageing with Metformin) study, run by the American Federation of Ageing Research.Verita is using the latest research to combine mainstream technologies and intelligent innovations with a personalised, preventative and integrated approach to aging, enabling us to offer next-generation customised healthcare, biological age reduction and aesthetic treatments. You can read the article in full here: https://www.raconteur.net/healthcare/ageing-disease

Bangkok, 14 November 2019 – Verita Neuro (formerly known as Unique Access Medical), a part of Verita Healthcare Group, successfully treated Ryan Straschnitzki, a former ice hockey player who was paralysed from the chest down after an unfortunate accident last year. Read more about his story and the breakthrough procedure here at BBC news page.

October 2nd 2019 – Verita Healthcare Group has entered into a joint venture with Minor Group’s Anantara Hotels, Resorts & Spas to collaborate on a global network of integrated, property-based health centres.

Singapore based multinational company, Verita joins Anantara in signalling growing confidence in medical and wellness tourism within Thailand and around the world. Wellness tourism is currently worth around $639bn annually* and this is set to rise rapidly over the coming years

The project recognises increasing demand for personalised innovative travel and wellness offerings that go beyond traditional fitness and spa services. Launching initially with a centre currently in development at the Anantara Riverside Bangkok and scheduled to open in Q1 2020, the JV plans to expand into multiple locations around Asia Pacific and Europe.

Verita Healthcare Group Founder and Chief Executive Officer Julian Andriesz says, “The AnantaraVerita partnership will allow people to take proactive, personalised steps towards extending their healthy lifespans, reversing the effects associated with aging, and enhancing their overall human performance – all within the luxury of a modern and comfortable environment. Minor Group have a database of over 70 million people and we look forward to launching Verita centres early next year in Thailand and then across their stunning flagship properties in Asia Pacific and Europe.”

The centre’s 677 sqm of modern luxury will feature dark IV infusion rooms with sleep-promoting light therapy, streamlined VIP suites, a meditative garden and ergonomically-designed private consultations pods.

Owing to aging populations and increasing levels of chronic diseases due to modern lifestyle habits, there has been a rise in the demand for more sophisticated, scientifically-based therapies and services focused on smart early prevention and life extension. The health facility’s treatment menu will reflect Verita’s distinct offerings combining the world’s most ground-breaking diagnostics and a cutting-edge digital health platform.

State-of-the-art technology provides advanced health analytics and reports in real-time for immediate consultation and recommendation of personalised programmes. The latest innovations such as the recovery XR cryotherapy chamber and vascular pulse therapy “cardiosynchronised vascular physiotherapy” specifically target issues such as biological age reduction and performance improvement. Whether clients are interested in customising diet and fitness plans to suit their genetics, whether they need to focus on specific areas of concern like weight, sleep, libido or immune system or they simply need a fast detox or energy boost they will find what they are looking for.

William E. Heinecke, Chairman and Founder of Minor International, owning company of Anantara Hotels, Resorts & Spas, commented on the joint venture, “We are excited to welcome Verita Healthcare Group to Bangkok, my home, and also the global capital of medical and wellness tourism. This partnership represents the coming together of one of the world’s largest and fastest growing luxury hotel brands with the world’s largest and fastest growing Next Generation Healthcare group. It’s a global first and, with the increasing demand for luxury tailored travel and wellness offerings, added to the fact that international wellness tourism on its own is expected to grow to USD1 Trillion by 2022 – we think the timing is perfect”.

About Verita Healthcare Group

Verita is an international healthcare group that empowers individuals and populations to detect, prevent and manage disease and significantly extend their healthy life-spans through the application of integrative, progressive and personalized health management approaches, products and techniques.

Founded in Singapore by Julian Andriesz, Verita has offices in Asia, Europe and Silicon Valley, the company works with medical professionals, protocols, science and technology to meet the world’s growing demand for smarter healthcare that focuses on proactive evidence-based disease prevention; and life extension, rather than reactive treatment.

With the global growth in digital healthcare currently running at over 38%, the global healthcare market is set to be worth US$111bn by 2025 and industry leader, Verita Healthcare Group is a fully integrated, scalable and profitable healthcare platform built around three clear business pillars featuring specialist clinics, product innovation and medical technology, analytics and Artificial Intelligence (A.I).

In addition to a strong and established management team, a vibrant community of medical advisors and a global panel of industry professionals, Verita collaborates with some of the world’s most advanced research and medical institutions to treat referred patients, co-develop new protocols and treatments, and explore advances in integrative healthcare.

www.verita.com

Contact: David Mayo +65 9615 3902 [email protected] for further details

London, 4 October 2019 – Verita Healthcare Group (“Verita”), an integrated provider of preventative, personalised healthcare, has strategically invested in three digital healthcare businesses as part of its international expansion and consolidation strategy.

Each business provides a range of customisable tools aligned with Verita’s aim to help people take control of their health and wellbeing through providing a range of cost effective, personalised digitally-enabled solutions:

• nBuddy is a chronic disease management (“CDM”) app focused on helping people with chronic illnesses – such as obesity, diabetes and hypertension – to manage and reverse their health issues. Its digital intervention programs, including expert nutritional and lifestyle advice and coaching, have been developed in Singapore to specifically cater for the huge Asia market.
• CelliHealth is a digital health and wellness platform for employers and insurers, providing healthy lifestyle education, gamified challenges, activity tracking, and incentives for hitting healthy lifestyle and wellness goals.
• Hanako provides a range of market-leading, real-time, AI-driven mobile health screening solutions onsite for employees of large corporates in Germany.

The acquisitions underline Verita’s aim to be one of the world’s leading integrative healthcare companies. The announcement coincides with the recent establishment of the company’s European HQ in London, which will act as a strategic base alongside its US headquarters in Silicon Valley.

In line with its ambitions, Verita is building a world-leading, multi-faceted digital platform for mass transformational health. The three investments will be incorporated into the Verita Wisdom platform, which offers people a range of tools to enable the early detection, prevention, management and reversal of the chronic diseases that drive over 70% of all global deaths and healthcare spend.  

Julian Andriesz, Founder, Verita Healthcare Group, commented:

“These targeted investments fit well with our long-term goal for Verita. We have a strong acquisition and partnership strategy which has seen Verita Wisdom grow quickly over the last 18 months. We plan to make more investments in the near future which will result in Verita Wisdom becoming the largest and best digital health platform in the world in terms of user base, services, geographical reach, proven outcomes and profitability.

“With each acquisition we look for a proposition that adds value to our clients, providing greater choice and smarter technology, as well the ability to integrate with our current services. With CelliHealth, nBuddy and Hanako we’ll be able to help more users take greater control of their health.

“The integration of these platforms under Verita Wisdom complements the Group’s other services, which include treatment and product manufacturing centres around the world, making proactive healthcare more accessible than ever.

Verita, which operates in eight countries currently, seeks to fill and augment the large gaps left by mainstream medicine, and lead the way in next generation healthcare.

For detailed information about Verita’s nBuddy, CelliHealth and Hanako investments please see the bottom of this release.

About Verita Healthcare Group

Verita is an international healthcare group that empowers individuals and populations to detect, prevent and manage disease and significantly extend their healthy life-spans through the application of integrative, progressive and personalized health management approaches, products and techniques.

Founded in Singapore by Julian Andriesz, Verita has offices in Asia, Europe and the USA, the company brings together medical professionals, with innovative science and technology to meet the world’s growing demand for smarter healthcare that focuses on proactive evidence-based disease prevention and life extension, rather than reactive diseise treatment.

With the global growth in digital healthcare currently running at over 38%, the global healthcare market is set to be worth US$111bn by 2025 and industry leader, Verita Healthcare Group is a fully integrated, scalable and profitable healthcare platform built around three clear business pillars featuring specialist clinics, product innovation and medical technology, analytics and Artificial Intelligence (A.I).

In addition to a strong and established management team, a vibrant community of medical advisors and a global panel of industry professionals, Verita collaborates with some of the world’s leading research and medical institutions to pioneer advances in integrative healthcare.

www.verita.com

About the apps:

CelliHealth – a digital wellness app that enables users to capture and analyse data from offline health screenings (e.g. annual health check) and their everyday health and lifestyle data from sync’d mobile health apps and IOT devices / wearables, to create health scores, reports and insights, leading to tailored recommendations on how to manage their lifestyle and personal health risks / issues to achieve their wellness goals.

Core features include setting health and wellness goals, tracking progress, accessing educational content and lifestyle tips, help to set up and follow healthier habits, access to relevant health and wellness communications and events, and so on.

The app, rebranded “Verita Wellness”, has added new features and functionality since acquisition, including engaging and fun challenges and incentives that encourage active participation, drive healthier lifestyle behaviour changes and, reward users’ for achieving health improvements.

The Verita Wellness app, primarily a B2B2C tool designed to support the health and wellness of large populations, will launch in Singapore in Q4 2019 to select clients including employees of corporations and members / patients of Verita’s insurance and healthcare partners.

From Q1 2020 the Wellness app will launch in other international markets and be extended to customers of Verita’s commercial / retail partners, and in the longer term be offered to citizens through government / health bodies.

nBuddy – a chronic disease management (“CDM”) app built in Singapore and primarily focused on supporting the needs of the huge Asian population of people who have chronic health issues such as obesity, diabetes and hypertension.

The platform provides tools plan and track healthy eating habits, adopt an active lifestyle and support positive behavioural change. It comprises meal planning, recipes, food, activity and biometric tracking, edutainment content, and is underpinned by nutrition coaches and chat groups.

With millions of dollars of funding nBuddy has proven, through both clinical trials and real-world commercial use, that their platform directly helps users achieve significant and sustainable improvements to address their issues, particularly substantial weight loss (average 5-10%) and reductions in A1c / blood glucose and blood pressure down to normal levels, as well as reversal of non-alcoholic fatty liver disease. Untreated, these CDM related factors directly lead to 75% of all deaths (through resultant heart disease, stroke, kidney failure, cancer, etc) and account for an estimated 80% of total healthcare spend that could otherwise be avoided.

Timeblock® named ‘Product of the Year’ at Global Health and Travel Awards

Singapore, 12 September 2019 – Verita Healthcare Group, a global provider of preventative, personalised healthcare and wellness clinics, has acquired a controlling position and global distribution rights for Timeblock^®, a breakthrough supplement in age reversal.

Timeblock^® is the culmination of 20 years of research by a group of leading scientists in Switzerland. What began originally as a research project into anti-cancer medicine evolved upon the discovery that several plants – out of the 118 species tested – also had remarkable anti-ageing properties.

Many years of testing and cultivation revealed that selected plants and grasses grown at ultra-high altitudes (over 1,500m) and in precise environmental conditions and locations, produced a nutritional density many thousand times higher than the same plants and seeds grown elsewhere. These intensified nutraceutical ingredients formed the basis of the Timeblock^® supplement – and later, the unique skincare range.

A human clinical trial conducted by Vienna University in 2017 showed that the active ingredients in Timeblock^®, when taken daily, reversed biological ageing markers on average by 17 percent over a six-month trial period (110 volunteers) – effectively turning the human ageing process on its head.

Julian Andriesz commented on the acquisition:

“The more we understood the Timeblock^® product, the more we liked it and saw the potential to take ownership of the supply chain and invest in the company to take it global.

“We know Timeblock® works, the trials show it works, and it has huge potential to create a better quality of life and longevity for people globally. Now, more of our clients around the world will be able to access Timeblock^® as we focus on market roll-outs in the US and Europe, with additional geographies planned in the coming months.”

Timeblock^® was awarded ‘Product of the Year’ at the Global Health Asia Pacific Summit in Bangkok on the 6th of September. Held at the prestigious Anantara Siam Hotel, the awards featured leaders and change-makers in the field of health, disease prevention and anti-ageing medicine. Verita also won ‘Integrated Health Clinic of the Year, Asia Pacific’, in addition to bagging ‘Product of the Year’ for Timeblock^®, its recent acquisition.

The ceremony marks the third year Verita has been crowned ‘Integrated Health Clinic of the Year’.

Verita CEO and Founder Julian Andriesz commented:

“We are obviously delighted that Verita has been awarded not one, but two awards, this year for our innovative global solution.

“Verita’s success is a culmination of decades of experience. Asia Pacific is a fast-growing region for us and winning these two awards validates all the hard work and tireless efforts of our researchers, scientists and doctors.

“At Verita, we never settle for second best and are passionate about providing customised, preventative healthcare, so that people can choose to live better, for longer. These awards reflect that Verita is the first choice for a new era of preventative medicine.”

About Timeblock
Timeblock began as a research project into cancer-prevention, and the analysis resulted in findings that identified several plants – out of the 118 species tested – as having remarkable anti-ageing properties.

These crops had been growing in high altitudes, and through experiments, our researchers realised that low CO2 level in the air, plus extreme temperature variability between day and night, are essential requirements for optimal herbal nutrients and microfauna to obtain perfect pH values. Therefore, we cultivate our ingredients under organic conditions at elevations of over 1,500m.

Clean and scientific, the Timeblock system is rich in plant-based, non-toxic ingredients. Our skin care range is paraben, SLS, fragrance and alcohol-free, and rigorously tested for safety and efficacy. The timeblock Day and Night capsules are Vegan, non-GMO, gluten and lactose free.

Germany – www.time-block.com
UK – www.timeblock.co.uk
Asia – www.timeblock.asia
Australia – www.timeblockaustralia.com

London,United Kingdom 4 June 2019 – Verita Healthcare Group, a vertically integrated provider of preventative and personalised healthcare, has appointed Mr Michael James Kirkwood, CMG, to its Board as an Independent Non-Executive Director. Michael’s appointment is linked to the Company’s strategic decision to locate its European headquarters in London as it builds the infrastructure and team to deliver its international ambitions.

Built on 12 years of research collaborations with some of the most progressive scientific institutions and practitioners in the world, Verita combines specialist clinic models, in-house product development and manufacturing, a comprehensive digital healthcare and disease management platform and an international R&D network.

This integrated approach is designed to meet the rapid growth in demand for smarter healthcare that focuses on proactive wellness rather than illness; the individual rather than the mass-market; evidence-based effective disease prevention; and ultimately life extension. Verita, which operates in eight countries currently, seeks to fill the gaps left by mainstream medicine and lead the way in next generation healthcare.

Michael is the current Independent Chairman at Ondra LLP, a Non-Executive Director at AngloGold Ashanti Limited and a Senior Independent Director at Bushveld Minerals Limited.

With a 31-year track record at Citigroup Inc., where he was latterly UK Head and Chairman of Corporate Banking, Michael held management positions across the UK, New York, Scandinavia and Switzerland. In London, Michael was Deputy Chairman of the British Bankers Association, Chairman of the Association of Foreign Banks, President of the Chartered Institute of Bankers and the inaugural Chairman of British-American Business Inc.

During his earlier career, Michael spent several years in Asia, based in Singapore, with the Ralli-Bowater Group. Michael has also served as a Director of the British Government’s UK Financial Investments Ltd. (UKFI), Chairman of healthcare entity, Circle Holdings plc, Deputy Chairman of PricewaterhouseCoopers Advisory Board and as a Non-Executive Director of Eros International plc and Kidde plc.

“We are delighted that Michael has joined our Board. Verita is growing rapidly around the world and  corporate governance and international business expertise are important to us. Appointing a Board member of Michael’s calibre and experience was not only a priority but validates our strategy and vision. I am confident that his counsel and insight will be invaluable as Verita establishes its London headquarters and continues its European expansion plans.”

Verita Healthcare Group Ltd (“VERITA” or “VHG”) today announced its acquisition of a 70% shareholding in Australia Vitamin and Sports Nutrition Pty Ltd (“AVS”).

AVS provides a range of services relating to Health Foods, Supplements, Vitamins and Complementary Medicines; from sourcing, supplying, packaging and contract manufacturing to development of customised products and innovative formulations. AVS’ specific areas of competence and interest support the growth in demand for organic, natural ingredients such as Super Foods and high-quality Supplements, and they have quickly established themselves as trusted suppliers to major brands in the Australian healthcare market as well as fast-growing specialist start-up brands.

Head-quartered in Singapore, VERITA specialises in next-generation customised, preventative healthcare – from advanced diagnostics, disease prevention and longevity medicine to integrative oncology – all designed to help clients extend healthy lifespans and optimise performance.

AVS is VERITA’s fourth investment in Australia and it complements the Group’s fast-expanding range of high-quality products that underpin the preventative, personalised health, wellness and anti-aging solutions offered across their international healthcare platform.

Australian annual complementary medicine sales now exceed A$4.7 billion representing a compound annual growth rate of 27% and AVS is well-positioned to service the four main categories of Vitamin and Dietary Supplements, Sports Nutrition, Herbal and Traditional Products, and Weight Loss. The global complementary medicine market is expected to reach a value of US$115 billion by 2020.

Julian Andriesz, CEO of the Verita Healthcare Group, said “AVS epitomizes the reasons why Australian manufactured products are highly regarded regionally for quality and safety and we will help them ride the explosive global growth in demand for supplement and nutritional products. The acquisition of AVS underlines our commitment to providing high quality products as part of our vertically integrated, holistic healthcare offering. VERITA is fast becoming a leader in the global preventative healthcare market and we are committed to empowering our clients to improve their health and wellbeing through the latest evidence-based treatments, products, and technologies.

“The team at AVS have built a strong reputation amongst their customer base for integrity, quality and service which aligns with VERITA’s philosophy and culture. We look forward to leveraging our synergies and developing a strong partnership.”

Mikko Helle, General Manager and owner of AVS, said “VERITA’s acquisition of AVS will help drive the continued growth of our business, across Australia and into the Asia Pacific region”.

Media Contact:
Simon Potter +852 650 12933 [email protected]

Verita Healthcare Group is the first vertically integrated International healthcare company focused on Integrative and Preventative Medicine. VERITA own oncology clinics in Asia, Europe and North America (“Verita Life”) and Health and Wellness clinics (including Advanced Diagnostics, Aesthetics, Disease prevention, Anti-aging and performance improvement, “Verita Health”). VERITA are also involved in Medical Tourism to ensure customers can find the best possible healthcare at an affordable price. VERITA have 23 current Research and Development collaborations with top medical and science universities internationally and are building an analytical platform for improving both diagnostic and prognostic capabilities by improving the overall outcome for patients and customers (“Verita Wisdom”). The Wisdom platform will feedback data to enhance the efficacy of the Verita’s products division (“Verita Innovate”) which includes compound pharmaceutical, cosmeceutical and nutraceutical manufacturing. This improves speed to market and customer experience.

For more information, please visit:
http://group.verita.com/en/

For a short video introduction, please visit:
https://www.youtube.com/watch?v=010SlYQ79J8&frags=pl%2Cwn

About Australia Vitamin and Sports Nutrition (AVS):

Australian Vitamin & Sports Nutrition Pty Ltd has grown to be one of the largest and most successful independently owned contract manufacturers in Australia. As an independent Contract Food, Vitamin, Supplement and Complementary Medicine Manufacturing and Sourcing operation, AVS offers comprehensive services to brands looking for an alternate supplier or to those looking for new concepts. AVS Nutrition has been built from a combined experience of more than 30 years in manufacturing and regulatory affairs in the food and pharmaceutical industries. The vision is to deliver customers a high-quality product, along with a level of customer service and satisfaction beyond any competitor in the market.

For more information, please visit:
https://avsnutrition.com.au

Singapore, 13 March 2018 – Julian Mark Andriesz, CEO of Verita Healthcare Group Limited, has been appointed President of the Cancer-Aid Foundation, a not-for-profit organisation duly registered under Swiss Foundation Law for the Supervision of Foundations in Switzerland.

The Cancer-Aid-Foundation is an international, neutral and independent organization that focuses on cancer research and has the goal of supporting new ways of improving diagnostic, preventive and therapeutic medical procedures. In order to find new therapeutic applications, the Cancer Aid Foundation supports universities and research centres worldwide.

The focus of these sophisticated therapeutic approaches that stem from areas of cancer molecular diagnostics, oncology and the conventional and complementary medicine, lies in looking for technology that demonstrates minimal side effects while having a low effect in terms of the patient’s quality of life. Only study projects are supported which have clear clinical benefits for cancer patients. This has to be proven accordingly during pre-assessments.

Julian Andriesz commented, “I am honoured to be able to contribute to the noble work of the Cancer-Aid Foundation and to expand its collaborations with top universities and research institutes around the world for the ultimate benefit of cancer suffers”.

Singapore, 17 July 2018 – Verita Healthcare Group Limited (“Verita” or the “Company” and together with its subsidiaries, the “Group”) has made a strategic equity investment in Hanako GmbH (Hanako).

Hanako, a leading preventative health services provider from Germany, has developed a sophisticated mobile health screening platform offering personal check-ups and assessments on-site at corporates.

Their innovative platform uses world-class portable MedTech devices to precisely capture personal health data using evidence-based examinations, then deliver personalised health informatics based on AI-enabled analysis and reporting in real-time. Their doctor rounds off each check-up with a detailed consultation on what the results mean, and what the individual should do next to address any health risks or issues identified.

With the surge in preventable chronic diseases accounting for 75% of deaths worldwide, and associated healthcare inflation adding unsustainable pressure to global economies, disease prevention is a hot topic affecting families, employers, insurers and governments.

Hanako Medical Director Prof. Uwe Nixdorff says “Many chronic disease conditions can be detected early and avoided through modifying lifestyle and harnessing medical technology to better monitor and manage health indicators. The need to change from reactive disease management into proactive disease prevention is urgently needed. Hanako arms individuals with the information they need to precisely understand their health, and knowledge of what they should do to prevent or reverse chronic disease.”

Hanako’s growing European client base includes large MNCs and they are now collaborating with Verita for international growth. Verita is an award-winning, global leader in healthcare that aims to combine the best medical technologies and scientific innovations with a personalised, preventive and integrative approach.

Under its “Verita Wisdom” advanced diagnostics offering, Verita is integrating Hanako’s scalable platform within its global Verita Health centres, starting with Bangkok which launched in early July 2018. Feedback from Verita’s clients on its new service has been very positive.

“Intelligently combining computer learning with human medical knowledge to ensure that patients’ health issues and risks are identified and proactively addressed as early as possible to optimally support individual health goals and help prevent chronic diseases aligns with our vision. We are positioned as a leading global provider of precise, preventative health solutions and Verita Wisdom, powered by Hanako’s platform, is an ideal extension to Verita’s holistic service portfolio for next-generation healthcare”, CEO Verita Healthcare Group Julian Andriesz said.

Verita and Hanako have also agreed to partner and roll-out mobile health screenings to corporations and insurance companies internationally.

Hanako Commercial Director Michael Mayr added “In Verita Healthcare Group, we are delighted to have found an investor who fits perfectly with our corporate values and with whom we will jointly drive Hanako’s strategic orientation and international success”.